Introduction
Expression of the proto-oncogene c-myc is generally induced by mitogenic stimuli and repressed by growthinhibitory cytokines such as transforming growth factor-b (TGFb), with the TGFb effectors SMAD3 and SMAD4 directly repressing the c-myc promoter (Chen et al., 2002) . c-myc downregulation is important for the cytostatic action of TGFb in normal epithelial cells, as its enforced expression can prevent cell cycle arrest (Alexandrow et al., 1995; Warner et al., 1999; Claassen and Hann, 2000) . The c-myc-encoded protein, Myc, is a transcription factor that can either activate or repress transcription (Hurlin and Huang, 2006; KleineKohlbrecher et al., 2006) . Myc directly acts to suppress the cytostatic action of TGFb. In particular, it represses the transcription of the TGFb-activated genes Cip1 and INK4b through interaction and functional interference with the transcription factors involved in their activation, including MIZ-1 and SMADs (Seoane et al., , 2002 Staller et al., 2001; Feng et al., 2002; Wu et al., 2003) . Thus, Myc and TGFb/SMAD signaling have clear antagonistic actions at the cellular and molecular levels. This antagonism, however, may not apply in all cell types and circumstances. In carcinomas, for example, repression of c-myc by TGFb is frequently lost (Chen et al., 2001) and TGFb acquires tumorpromoting activities, most notably the induction of epithelial-to-mesenchymal transition (EMT) (Oft et al., 2002) . Whether c-myc and TGFb functionally interact in these circumstances has not been documented. Here, we address the hypothesis that Myc might have a positive role in TGFb signaling.
Results
We used RNA interference (RNAi) to downregulate Myc expression in the normal mouse mammary epithelial cell line NMuMg ( Figure 1a ) and to address its role in cellular responses to TGFb, and in particular in EMT. To minimize the proliferative defects caused by Myc downregulation, the c-myc knockdown was achieved within a short time frame (o2 days) by lentiviral infection, immediately followed by TGFb treatment and analysis. During the induction of EMT by TGFb, expression of E-cadherin is reduced and cells acquire increased migratory properties, thus placing the control of E-cadherin expression at the center of a tightly controlled mechanism by which cells can modulate their morphology (Zavadil and Bottinger, 2005) . EMT induction in NMuMg cells was followed through morphological changes, redistribution of E-cadherin and b-catenin from cell-cell interfaces (Figure 1b) as well as through the reduction in E-cadherin levels (Figure 1d , control) (Miettinen et al., 1994; Piek et al., 1999; Thiery, 2002 Thiery, , 2003 . These responses to TGFb were blunted in cells pretreated with c-myc RNAi: 24 h after TGFb addition, Myc-interfered cells did not efficiently redistribute E-cadherin and b-catenin, maintained an epithelial phenotype comparable with that of untreated control cells ( Figure 1c , compare with 1b) and maintained E-cadherin levels elevated (Figure 1d ). E-cadherin was reported to be transcriptionally regulated by Myc (Batsche et al., 1998) , but no significant changes in E-cadherin mRNA were seen in Myc-deficient NMuMg cells (data not shown). As cells start to loose E-cadherin, mesenchymal markers such as N-cadherin, fibronectin and vimentin are upregulated and cells take on a fibroblastic phenotype (Thiery and Sleeman, 2006) . In agreement with earlier publications (Miettinen et al., 1994) , fibronectin mRNA was induced in control cells after 24 h of TGFb treatment, an effect that was reduced in Myc-deficient cells (Figure 1e ). In conclusion, Myc is required for TGFb to effectively induce an EMT. Multiple transcription factors, such as snail, slug, E12/47, SIP1 and delta EF1, function as repressors of Ecadherin transcription and inducers of EMT (Batlle et al., 2000; Cano et al., 2000; Grooteclaes and Frisch, 2000; Comijn et al., 2001; Perez-Moreno et al., 2001; Bolos et al., 2003) . Snail mRNA levels were rapidly and transiently induced upon TGFb treatment in control, but not in Myc-deficient NMuMg cells, whereas the induction of Slug, SIP1 and E12/47 and of the TGFb target gene PAI-1 was Myc-independent ( Figure 2a and data not shown). Snail protein levels reproducibly responded to TGFb in a modest and delayed manner (5 h) relative to the mRNA, but most importantly this response was also Myc-dependent (Figure 2b ). The expression of human c-myc rescued induction of the Snail mRNA in the presence of the shRNA (short hairpin RNA) targeting mouse c-myc (Figure 2c ), ruling out off-target effects in our RNAi experiments. The dependence on c-myc for Snail upregulation was confirmed in human MDAMB231 cells (Figure 2d ). Most importantly, the requirement of Myc for the rapid induction of Snail must precede its eventual downregulation by TGFb: this was indeed the case, as NMuMg cells started downregulating Myc expression 3 h after TGFb treatment, whereas MDAMB231 cells did not downregulate it for at least 5 h (Figure 2e and data not shown).
We then addressed whether Snail is a direct Myc target gene. The human Snail promoter contains two canonical Myc-binding sites (the E-box consensus CACGTG) at positions À652 and À542 relative to the transcription start site (TSS; Supplementary Figure 1) . The second E-box is within a CpG island, constituting a strong predictive criterion for Myc binding (Fernandez et al., 2003; Guccione et al., 2006) . Quantitative chromatin immunoprecipitation (qChIP) analysis in growing MDAMB231 cells revealed low but significant binding of Myc and its dimerization partner Max in the region of the E-boxes, as well as the TSS (Figure 3a) . Myc binding to Snail was confirmed in the colon cancer cell line HCT116, the human monocytic cell line U937 and the B-cell line P493 (Supplementary Figures 2 and  3a) : in the latter cell line, the promoter had an active chromatin configuration prior to Myc binding and showed Myc-induced acetylation of histones H3/H4, which are common characteristics of Myc target genes ( Supplementary Figures 3b-g ) (Frank et al., 2001; Fernandez et al., 2003; Guccione et al., 2006) . The mouse Snail promoter did not contain a CACGTG consensus, but a CGCGTG variant at position À359, which aligned with the second E-box of the human promoter and was also within a CpG island (Supplementary Figure 1 ). About one-third of Myc target promoters contain a CpG island without a canonical CACGTG site (Guccione et al., 2006) , and CGCGTG (and its complement CACGCG) is one of the variant sites that may be targeted by Myc (Grandori et al., 1996) . The qChIP analysis revealed that Myc and Max were enriched on sequences from À517 bp through the TSS in NMuMg cells (Figure 3b ). Thus, Myc bound equivalent regions of the Snail promoter in mouse and human cells, consistent with its requirement for Snail induction in both species. The presence of Myc on chromatin prior to TGFb treatment suggests that it may act as a priming step for subsequent transcriptional activation. Most importantly, TGFb treatment within the time span of Snail induction had no significant effect on Myc/Max binding ( Figure 3 and data not shown).
We then used qChIP analysis to address whether SMADs directly target the Snail promoter. The only antibody against SMAD2 or SMAD3 that proved effective in this assay recognized both proteins, with a preference for SMAD3. This revealed binding to the TSS in MDAMB231 cells, peaking 30 min after TGFb treatment (Figure 4a ). Although low, this qChIP signal was specific, as it was lost in cells depleted for SMAD3 (Supplementary Figure 4) . The murine Snail TSS was similarly bound by SMAD2/3 in NMuMg cells (Figure 4b ). Knockdown of SMAD3 in either cell line impaired Snail induction by TGFb (Figures 4c and d) , whereas knockdown of SMAD2 (obtained only in MDAMB231 cells) had no significant effect. This appears consistent with the selective requirement of SMAD3 for the downregulation of E-cadherin (Phanish et al., 2006) . Owing most likely to the relatively low levels of SMAD complexes on Snail relative to other target loci (such as ID1, Figures 4a and b) , we could not detect significant enrichment of SMAD4 by qChIP analysis. However, as assayed by RNAi, SMAD4 was required for Snail induction by TGFb in both MDAMB231 and NMuMg cells (Figures 4c and d) , consistent with earlier data in the latter cells (Deckers et al., 2006) . The induction of PAI1 was also SMADdependent (data not shown) (Levy and Hill, 2005) . Altogether, the SMAD2/3 ChIP data and the requirement of SMAD3 (but not SMAD2) and SMAD4 suggest that Snail is targeted preferentially by (Frank et al., 2001) and represent the average and standard deviation from three parallel experiments. The PCR amplicons used for qChIP analysis of Snail are defined by the position of the 5 0 -primer relative to the transcription start site, TSS. Where indicated, the amplicons included either E-box1 or E-box2 in the human promoter, or the variant CGCGTG site in the mouse promoter. An alignment of the promoters is shown in Supplementary Figure 1 . PCR primer sequences are listed in Supplementary Table 1, including additional Snail sequences in either the 5 0 or 3 0 direction: none of these additional sites showed Myc enrichment (data not shown). SMAD3/4 complexes. As SMAD and Myc binding to the Snail promoter were overlapping (Figures 3 and 4) , we investigated their interdependency. Knockdown of either SMAD3 or SMAD4 in untreated MDAMB231 cells had no significant effect on Myc binding (Supplementary Figure 5 ). Reciprocally, Myc RNAi in either MDAMB231 or NMuMg cells did not significantly impair SMAD2/3 binding upon TGFb treatment (Supplementary Figure 5b and c) . Thus, binding of Myc and SMAD to DNA is not interdependent, and their functional interaction in promoting Snail transcription must occur at a subsequent step.
We then sought to investigate whether Myc participates to Snail activation in different circumstances. c-myc responds to mitogenic signals in quiescent fibroblasts and is required for the secondary activation of several target genes (Frank et al., 2001) . To address Snail regulation in this context, we used 3T9 fibroblasts bearing a conditional knockout allele of c-myc and expressing a 4-hydroxy-tamoxifen-inducible Cre recombinase (myc flox/flox -CreER cells) (Trumpp et al., 2001) . Near-confluent cultures were serum-starved for 48 h, with or without concomitant 4-hydroxy-tamoxifen treatment to trigger c-myc deletion: upon re-stimulation with serum, the c-myc mRNA was induced in control, but not in 4-hydroxy-tamoxifen-treated cells (Figure 5a) . Induction of the Myc target genes Ncl or Ppat was blunted upon c-myc deletion (Figures 5b and c) . Snail also responded to serum, but did so in a Mycindependent manner (Figure 5d ). As assayed by qChIP, Myc was associated with the Snail promoter upon serum stimulation, with a pattern that was very similar to that seen in NMuMg cells (Figure 5e , compare with Figure 3b ). Thus, although it bound to the promoter, Myc was not required for Snail induction is this context.
In epithelial cells, multiple signaling pathways besides TGFb-including epidermal growth factor, hepatocyte growth factor (HGF), fibroblast growth factor and (Figure 6a ). Most remarkably, the same was true for SMAD4 RNAi (Figure 6b ). Although HGF can in some instances suppress TGFb signaling (Yang et al., , 2005 Dai and Liu, 2004) , it can also induce SMAD2 phosphorylation (de Caestecker et al., 1998) . In summary, different signals can act through SMADs in the activation of Snail transcription in epithelial cells: as shown here for TGFb and HGF, these signals also have in common the requirement of Myc.
Discussion
We have shown that Myc and TGFb cooperate in the induction of Snail transcription and of an EMT in cultured epithelial cells, in apparent contrast with their well-established antagonism in the regulation of genes such as Cip1 or INK4b, as well as in growth control (Seoane et al., , 2002 Staller et al., 2001; Feng et al., 2002; Wu et al., 2003) . However, these two modes of interaction are not contradictory and may in fact coexist in cells, acting at different time points and on different target genes. Myc was bound to the Snail promoter in proliferating cells independent from TGFb, and was required for the rapid and transient induction of the Snail mRNA upon TGFb treatment. However, Myc was not required for TGFb to induce binding of SMAD complexes to the promoter, implying that these transcription factors cooperate at a post-DNA-binding step. Myc may either prime the Snail promoter to allow its immediate activation by SMADs or, most likely, may cooperate with DNA-bound SMADs, perhaps in the recruitment of co-activator complexes. The reported protein-protein interaction between Myc and SMADs (Feng et al., 2002) may also contribute to their cooperative activity. When observed, the downregulation of c-myc by TGFb occurred in a delayed manner, and could therefore not impinge on the early induction of Snail. On the other hand, c-myc downregulation will be instrumental in allowing the SMAD-dependent activation of Myc-repressed genes, such as Cip1 or INK4b (Seoane et al., , 2002 Staller et al., 2001; Feng et al., 2002; Wu et al., 2003) . Thus, the functional interplay between Myc and SMADs is exquisitely dependent on promoter context and results in distinct kinetic responses.
At the molecular level, our data provide an additional paradigm for the cooperation of Myc with different transcription factors, as already shown for the estrogen receptor (Cheng et al., 2006) and E2F1 (Leung et al., 2008) . This is also suggested by the binding of Myc and several other factors to common promoters, for example in embryonic stem cells (Chen et al., 2008; Kim et al., 2008a) . Genome interaction studies, in different cell types and species, altogether indicate that Myc binds thousands of genomic loci (Gallant et al., 1996; Zeller et al., 2001; Fernandez et al., 2003; Li et al., 2003; Mao et al., 2003; Chen et al., 2008; Kim et al., 2008a, b) . An even larger series of gene expression studies suggests that Myc fails to coordinately regulate most of those target loci in any given cell type and/or condition. For example, we showed that Myc determines the responsiveness of Ncl, Ppat and several other target genes to serum mitogens in rodent fibroblasts, but is unable to induce most of those genes if targeted to their promoters in the absence of serum (Frank et al., 2001) . Our current data suggest that the Myc-dependent serum response involves close to 100 target genes (D Perna and B Amati, unpublished data). Most remarkably, in spite of the fact that Myc associated with the Snail promoter in serumstimulated fibroblasts, it was not required for Snail activation (in fact, Snail appeared to be induced slightly better in c-myc-deleted fibroblasts), in stark contrast with the TGFb response in epithelial cells.
It is also noteworthy that not all promoters that are targeted by Myc and SMADs may be cooperatively regulated by those factors in epithelial cells: the PAI1 promoter, for example, contains an E-box consensus site that was targeted by Myc (Fernandez et al., 2003) , but Myc was not required for PAI1 activation by TGFb (Figure 2a ). This may in part be explained by the fact that a different E-box-binding protein, TFE3, can cooperate with SMADs for PAI1 activation (Hua et al., 1998 (Hua et al., , 1999 . Together, the above observations provide further illustrations of the concept that transcriptional regulation by Myc is context-dependent and that Myc binding cannot simply be equated to gene activation (Frank et al., 2001) . In this context, it will be particularly relevant to determine whether Myc and TGFb/SMAD signaling synergistically regulate other genes besides Snail in epithelial cells.
Altogether, we surmise that the widespread interaction of Myc with genomic loci is converted into more restricted cell-or signal-dependent transcriptional programs through cooperative interactions with specific transcription factors: these responses may involve any number of genes, and may even be limited to one or few specific targets (Cheng et al., 2006) . This is likely to be a key principle in transcriptional regulation by Myc and other transcription factors that target large numbers of genomic loci.
Finally, we have shown that the cooperation between Myc and SMADs in Snail induction applies not only to TGFb but also to HGF signaling, and most likely to other signals that act through SMAD complexes. Through its role in Snail regulation, Myc may be instrumental in allowing those signals to modify tissue architecture and induce cellular motility (Carver et al., 2001; Zha et al., 2007) . In carcinomas that lose downregulation of c-myc and therefore also cell cycle arrest in response to TGFb (Chen et al., 2001) , Myc may also cooperate with TGFb in promoting invasiveness and metastasis, warranting careful reassessment of Myc's role in these pathological processes. DMEM (Dulbecco's modified Eagle's medium) supplemented with 4.5 g/l glucose, 10% fetal bovine serum, 10 mg/ml insulin, 100 U/ml penicillin and 100 mg/ml streptomycin. EMT was induced in NMuMg cells by treating subconfluent cells for 24 h with 5 ng/ml TGFb (R&D Systems, Minneapolis, MN, USA) (Miettinen et al., 1994; Piek et al., 1999) . NM18 cells expressing an SMAD4 shRNA and the corresponding control cells were derived earlier from NMuMG cells (Deckers et al., 2006 ) (a gift from P ten Dijke). Human MDAMB231 cells and mouse myc flox/flox -CreER cells (a gift from T Oskarsson and A Trumpp) were cultured in DMEM supplemented with 10% fetal bovine serum, 100 U/ml penicillin and 100 mg/ml streptomycin.
Materials and methods

Cell culture
qChIP and mRNA analysis NMuMg, MDAMB231, P493-6, U937 and HCT116 cells were grown and processed for qChIP following our original protocol (Frank et al., 2001; Fernandez et al., 2003) . Immunoprecipitated DNA from 10 7 cell equivalents was resuspended in 200 ml of 10 mM Tris at pH 8.0. Real-time PCR was performed with 6 ml of DNA per reaction and 200 nM primers, diluted in a final volume of 20 ml in SYBR Green Reaction Mix (Perkin Elmer, Boston, MA, USA) with the primers listed in Supplementary Table 1. Total RNA from MDAMB231 and NMuMg cells was prepared with the RNeasy Kit (Qiagen, Valencia, CA, USA). Complementary DNA was produced using the reverse transcriptase SuperScriptII (Invitrogen, Carlsbad, CA, USA). Real-time PCR was performed with 10 ng of cDNA per reaction and 800 nM primers, diluted in a final volume of 20 ml in SYBR Green Reaction Mix (Perkin Elmer) with the primers listed in Supplementary Table 2. 36B4 (also Rplp0) was used for normalization in both mouse and humans. All the statistical analysis was performed using two-tailed Student's t-test.
Antibodies
The antibodies used for ChIP, western blotting and immunohistochemistry were the following: c-Myc (N262), max (C-17), PolII (N-20) and SMAD4 (C-20 and H-552; all from Santa Cruz Technology, Santa Cruz, CA, USA); ab8580 H3K4me3 (Abcam, Cambridge, UK); 06-866 H4pan-ac, 06-599 H3pan-ac, 07-473 H3K4me3, ab3817 SMAD3, 06-920 SMAD3, 07-408 SMAD2-3 and ab17732 Snail (Upstate, Lake Placid, NY, USA); 51-1300 SMAD2 and 51-1500 SMAD3 (Zymed, South San Francisco, CA, USA); 610181 E-cadherin (BD Transduction Laboratories, Franklin Lakes, NJ, USA) and V 19131 vinculin (Sigma, St Louis, MO, USA).
RNAi
For Myc, SMAD2, SMAD3 and SMAD4 knockdown experiments, cells were infected with a Lentilox-Puro lentiviral vector (modified from LentiLox-GFP) (Rubinson et al., 2003) expressing shRNAs complementary to the corresponding mRNA. The target sequences are listed in Supplementary  Table 3 . Infectious lentiviruses were produced by transfection into 293T packaging cell lines.
